Retail pharmacy drug sales in 13 major markets grew 5% overall at both constant exchange rates and in US$ terms, during the 12 months to December 2006, reaching $388.28 billion, reports IMS Health's Retail Drug Monitor. The rate of increase remains unchanged since April 2006 (Marketletters passim), although the constant exchange rate value has fluctuated from 3% to 5% since August last year.
Brazil, the fastest-growing market, halted its relative slow-down from 36% annual growth for the year ending July 2006, staying at 24% for both November and December, at $8.37 billion, while Mexico dipped to 8% at $8.10 billion and Argentina held a 12% rise for $2.29 billion. Overall, the leading players in the Latin American market grew 15%, from 17% in November 2006.
USA lead grows in IMS markets
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze